IDH1 and glioblastoma: Nonetheless, IDH mutations in low-grade diffuse astrocytomas ranges from 57 to 88% and almost all pilocytic astrocytomas and primary glioblastomas stains IDH-negative (Camelo-Piragua et al., 2010; Cai et al., 2016; Louis et al., 2016).